Search - tctmd.com

Displaying 201 - 220 of 654

Sort: Relevancy | Date

News Daily News

Clopidogrel Holds Advantage in Older NTSE ACS Patients: POPular AGE Published

Michael O'Riordan

April 27, 2020

News Features

Hopes High for Anti-inflammatories to Combat COVID-19 Immune System Storms

Caitlin E. Cox

April 23, 2020

News Daily News

Smoker’s Paradox Debunked: Post-STEMI Outcomes Worse in Cigarette Smokers

Michael O'Riordan

April 15, 2020

News Conference News ACC 2020

Aspirin Okay for Up to 30 Days in A-fib Patients After ACS or PCI: AUGUSTUS

Todd Neale

April 03, 2020

News Conference News ACC 2020

TICO: Ticagrelor Monotherapy After 3 Months of DAPT Curbs Bleeding in Stented ACS Patients

Todd Neale

March 31, 2020

News Conference News ACC 2020

Safety, Efficacy of Ticagrelor Monotherapy Confirmed in Complex PCI, Diabetes

Yael L. Maxwell

March 30, 2020

News Daily News

COVID-19 Poised to Upend the Cath Lab, ACC and SCAI Say

Caitlin E. Cox

March 18, 2020

News Daily News

Potent Antithrombotic Therapy Cuts Spontaneous MI After PCI for ACS

Yael L. Maxwell

March 10, 2020

News Daily News

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

Shelley Wood

February 28, 2020

News Conference News CRT 2020

Good Coronary Collateral Circulation? Better LVEF and Survival After STEMI

Michael O'Riordan

February 24, 2020

News Daily News

Snapshot of Revascularization Outcomes Offers Some Reassurances, Some Surprises

Shelley Wood

February 14, 2020

News Daily News

Outcome Differences Between Men and Women With PAD: EUCLID Insights

L.A. McKeown

February 11, 2020

News Daily News

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

Michael O'Riordan

February 10, 2020

Presentation

Utilization and Outcomes of Measuring FFR in Patients With Stable Ischemic Heart Disease

January 28, 2020

News Daily News

FFR for Stable Patients With Intermediate CAD? VA Analysis Stokes Debate

Michael O'Riordan

January 27, 2020

News Daily News

Clopidogrel Interaction With Morphine in ACS Linked to More Ischemic Events

Shelley Wood

January 20, 2020

News Daily News

No Fewer MACE With Ticagrelor vs Clopidogrel in ACS Patients After PCI: Registry

Todd Neale

January 15, 2020

News Daily News

Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes

Michael O'Riordan

January 14, 2020

News Daily News

Counting CPCs May Beat Stress Tests for Stratifying CAD Risk

Yael L. Maxwell

December 11, 2019

News Features

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

Michael O'Riordan

December 09, 2019

Advertisement

Clopidogrel Holds Advantage in Older NTSE ACS Patients: POPular AGE Published

Hopes High for Anti-inflammatories to Combat COVID-19 Immune System Storms

Smoker’s Paradox Debunked: Post-STEMI Outcomes Worse in Cigarette Smokers

Aspirin Okay for Up to 30 Days in A-fib Patients After ACS or PCI: AUGUSTUS

TICO: Ticagrelor Monotherapy After 3 Months of DAPT Curbs Bleeding in Stented ACS Patients

Safety, Efficacy of Ticagrelor Monotherapy Confirmed in Complex PCI, Diabetes

COVID-19 Poised to Upend the Cath Lab, ACC and SCAI Say

Potent Antithrombotic Therapy Cuts Spontaneous MI After PCI for ACS

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

Good Coronary Collateral Circulation? Better LVEF and Survival After STEMI

Snapshot of Revascularization Outcomes Offers Some Reassurances, Some Surprises

Outcome Differences Between Men and Women With PAD: EUCLID Insights

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

Utilization and Outcomes of Measuring FFR in Patients With Stable Ischemic Heart Disease

FFR for Stable Patients With Intermediate CAD? VA Analysis Stokes Debate

Clopidogrel Interaction With Morphine in ACS Linked to More Ischemic Events

No Fewer MACE With Ticagrelor vs Clopidogrel in ACS Patients After PCI: Registry

Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes

Counting CPCs May Beat Stress Tests for Stratifying CAD Risk

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content